CAS 1185241-19-3

Formel: C14H15N3O5

InChl: InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+/i1D3,2D3,3D2,4D2

InChI Key: JRURYQJSLYLRLN-YFIMXNTNSA-N

SMILES: [2H]C([2H])([2H])C([2H])([2H])N(C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N)C([2H])([2H])C([2H])([2H])[2H]

Entacapone-d10

CAS: 1185241-19-3

Entacapone-d10

Formel: C₁₄H₅D₁₀N₃O₅

Reinheit: 98%

Molekulargewicht: 315.35

Ref: 54-DE3231

Entacapone-d10

CAS: 1185241-19-3

Formel: C₁₄H₅D₁₀N₃O₅

Farbe und Form: Yellow Solid

Molekulargewicht: 315.35

Ref: 4Z-E-033

Entacapone-d10(N,N-diethyl-d10)

CAS: 1185241-19-3, 130929-57-6

Reinheit: 99 atom % D

Farbe und Form: Yellow To Brown Solid

Molekulargewicht: 315.35

Ref: 3U-D6835

Entacapone-d10

Kontrolliertes Produkt

CAS: 1185241-19-3

Applications (E)-Isomer of labelled Entacapone polymorphic form A. Peripherally acting inhibitor of catechol-O-methyl transferase (COMT), an enzyme involved in the metabolism of catecholamine neurotransmitters and related drugs. Antiparkinsonian.
References Karlsson, M., et al.: J. Pharm. Biomed. Anal., 10, 593 (1992), Nissinen, E., et al.: Arch. Pharmacol., 346, 262 (1992), Wikberg, T., et al.: Eur. J. Drug Metab. Pharmacokinet., 18, 359 (1993),

Formel: C₁₄D₁₀H₅N₃O₅

Farbe und Form: Neat

Molekulargewicht: 315.348

Ref: TR-E558502